Body composition analyses from clinical studies indicate that a portion of weight lost may be lean mass rather than fat mass
Several important safety considerations from the SmPC should be noted: If pancreatitis is suspected, Ozempic should be discontinued immediately and urgent medical assessment sought Patients should be counselled about gallbladder disease symptoms, as GLP-1 receptor agonists may increase the risk of gallstones [14] Those with pre-existing diabetic retinopathy should be monitored for potential worsening, particularly during rapid improvement in glucose control If a patient is taking warfarin or other coumarin derivatives, more frequent INR monitoring is recommended when starting Ozempic [1] Before initiating Ozempic in patients with known liver conditions, healthcare professionals should conduct a thorough assessment of liver disease severity, review concurrent medications for potential interactions, and establish baseline liver function tests
Underlying health conditions If you have any health conditions, that can also affect how quickly semaglutide works for weight loss
in Physician Assistant Studies, Towson University/CCBC Essex B.A
GLP-1 Drugs Offer More Than Weight Loss and Glucose Control Tirzepatide, semaglutide more efficacious than other FDA-approved drugs for weight loss New GLP-1 Data Reinforce CV Benefit Addiction, depression, cognition: How GLP-1s may benefit the brain Intentional weight loss of 5% or more cuts risk for death among postmenopausal women Lifting from head to toe: Weight-loss drugs boost popularity of surgeries to remove extra skin | CNN Are GLP-1s the Newest Fertility Treatment